
Phase II Data Land Merck’s Welireg FDA Approval for Advanced, Unresectable, or Metastatic Pheochromocytoma or ...
Key takeaways 1. Regulatory milestone for rare tumors: Merck’s Welireg received FDA approval for treating advanced PPGL in patients aged 12+, marking the first non-surgical treatment option for this rare condition and highlighting the importance of …